A Prospective, Ultrasound-Based Study to Evaluate Risk Factors for Uterine Fibroid Incidence and Growth: Methods and Results of Recruitment

Journal of Women's Health

Volumn 24, Issue 11, 2015, Pages 907-915

  Baird, Donna D ^a   Harmon, Quaker E ^b   Upson, Kristen ^a   Moore, Kristen R ^a   Barker Cummings, Christie ^b   Baker, Susan ^b   Cooper, Tracy ^c   Wegienka, Ganesa ^d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; GENITAL TRACT INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; TUMOR GROWTH; URINE; UTERUS MYOMA; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; ETHNOLOGY; EVALUATION STUDY; LEIOMYOMA; METHODOLOGY; PATIENT SELECTION; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTERUS CANCER; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEIOMYOMA; PATIENT SELECTION; PROSPECTIVE STUDIES; REPRODUCTIVE TRACT INFECTIONS; RESEARCH DESIGN; SURVEYS AND QUESTIONNAIRES; ULTRASONOGRAPHY; UNITED STATES; UTERINE NEOPLASMS; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84947057587     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2015.5277     Document Type: Article

References (42)

1. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 2003;188:100-107.
2. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 2002;99:229-234.
3. Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 2008;14:CR24-31.
4. Cardozo ER, ClarkAD, BanksNK, HenneMB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 2012;206:211 e211-219.
5. Perez-Lopez FR, Ornat L, Ceausu I, et al. EMAS position statement: Management of uterine fibroids. Maturitas 2014; 79:106-116.
6. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-438.
7. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect 2003;111:1037-1054.
8. Bulun SE. Uterine fibroids. N Engl J Med 2013;369:1344-1355.
9. Velebil P, Wingo PA, Xia Z, Wilcox LS, Peterson HB. Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States. Obstet Gynecol 1995;86:764-769.
10. Becker ER. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures. J Health Care Finance 2007;33:1-16.
11. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: An ultrasound-screening study. Obstet Gynecol 2009;113:630-635.
12. Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med 2010;28:204-217.
13. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90:967-973.
14. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol 2005;105: 563-568.
15. Wise LA, Laughlin-Tommaso SK. Chapter 19 -Uterine Leiomyomata. In: Goldman MB, Troisi R, Rexrode KM, eds. Women and health, 2nd ed. San Diego: Academic Press; 2013: 285-305.
16. Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: Low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand 2000;79:202-207.
17. Bower JK, Schreiner PJ, Sternfeld B, Lewis CE. Black-white differences in hysterectomy prevalence: The CARDIA study. Am J Public Health 2009;99:300-307.
18. Eskenazi B, Warner M, Samuels S, et al. Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women's Health Study. Am J Epidemiol 2007;166:79-87.
19. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med 2011;364:248-254.
20. Blauer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril 2008.
21. Halder SK, Goodwin JS, Al-Hendy A. 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J Clin Endocrinol Metab 2011; 96: E754-762.
22. Halder SK, Sharan C, Al-Hendy A. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model. Biol Reprod 2012;86:116.
23. Sharan C, Halder SK, Thota C, Jaleel T, Nair S, Al-Hendy A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil Steril 2010;95:247-253.
24. BairdDD, HillMC, SchectmanJM,HollisBW. Vitamin d and the risk of uterine fibroids. Epidemiology 2013;24:447-453.
25. Halder SK, Osteen KG, Al-Hendy A. Vitamin D3 inhibits expression and activities ofmatrixmetalloproteinase-2 and -9 in human uterine fibroid cells. Hum Reprod 2013;28:2407-2416.
26. Sabry M, Halder SK, Allah AS, Roshdy E, Rajaratnam V, Al-Hendy A. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: A cross-sectional observational study. Int J Womens Health 2013;5:93-100.
27. Al-Hendy A, Diamond MP, El-Sohemy A, Halder SK. 1, 25-dihydroxyvitamin D3 Regulates Expression of Sex Steroid Receptors in Human Uterine Fibroid Cells. J Clin Endocrinol Metab 2015:jc20144011.
28. Halder SK, Osteen KG, Al-Hendy A. 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells. Biol Reprod 2013; 89: 150.
29. Witherspoon JT, Butler VW. The etiology of uterine fibroids with special reference to the frequency of their occurrence in the Negro: An hypothesis. Surg Gynecol Obstet 1934;58: 57-61.
30. Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol 2006;195:415-420.
31. Wegienka G. Are uterine leiomyoma a consequence of a chronically inflammatory immune system? Med Hypotheses 2012;79:226-231.
32. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996;41:483-490.
33. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395.
34. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-469.
35. Muram D, Gillieson M, Walters JH. Myomas of the uterus in pregnancy: Ultrasonographic follow-up. Am J Obstet Gynecol 1980;138:16-19.
36. Fedele L, Bianchi S, Dorta M, Brioschi D, Zanotti F, Vercellini P. Transvaginal ultrasonography versus hysteroscopy in the diagnosis of uterine submucous myomas. Obstet Gynecol 1991;77:745-748.
37. Kupfer MC, Schiller VL, Hansen GC, Tessler FN. Transvaginal sonographic evaluation of endometrial polyps. J Ultrasound Med 1994;13:535-539.
38. Reinhold C, Tafazoli F, Wang L. Imaging features of adenomyosis. Hum Reprod Update 1998;4:337-349.
39. Wilde S, Scott-Barrett S. Radiological appearances of uterine fibroids. Indian J Radiol Imaging 2009;19:222-231.
40. Moshesh M, Peddada SD, Cooper T, Baird D. Intraobserver variability in fibroid size measurements: Estimated effects on assessing fibroid growth. J Ultrasound Med 2014;33: 1217-1224.
41. Peddada SD, Laughlin SK, Miner K, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A 2008;105:19887-19892.
42. Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women's Health Study: A follow-up study for causes and preventions of illness. J Am Med Womens Assoc 1995;50: 56-58.